Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China flag China · Delayed Price · Currency is CNY
8.40
-0.13 (-1.52%)
May 20, 2026, 11:29 AM CST

SHA:603707 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,2701,3951,0241,2101,389658.55
Trading Asset Securities
1,1171,3171,055681.991.3259.8
Cash & Short-Term Investments
3,3872,7112,0801,8921,390918.35
Cash Growth
136.76%30.35%9.94%36.12%51.34%-31.43%
Accounts Receivable
1,1251,229920.04771.68974.11897.75
Other Receivables
243.78235.35273.46230.88241.94167.88
Receivables
1,3691,4651,1941,0031,2161,066
Inventory
3,0303,2653,6754,1585,6164,894
Prepaid Expenses
--13.1711.988.467.98
Other Current Assets
109.1279.4284.42196.9964.1443.62
Total Current Assets
7,8957,5207,0467,2628,2946,930
Property, Plant & Equipment
1,1771,1921,1971,2351,198827.42
Long-Term Investments
91.2792.0883.2672.4861.626.39
Goodwill
124.66126.64129.51127.61125.48114.87
Other Intangible Assets
398.78410.37337.53174.1118.96123.85
Long-Term Deferred Tax Assets
138.1136.07203.25348.4101.4734.54
Long-Term Deferred Charges
819.15774.46459.55294.2494.6277.65
Other Long-Term Assets
48.8590.6853.710.3816.3182.34
Total Assets
10,69310,3439,5109,52410,0108,217
Accounts Payable
559.51589.12495.66537.74505.12458.87
Accrued Expenses
209.84264.6207.11294.8588.1564.56
Short-Term Debt
1,7531,4261,2361,5671,9571,571
Current Portion of Long-Term Debt
843.26842.988.21505.450.42-
Current Income Taxes Payable
20.33-3.7229.310.448.73
Current Unearned Revenue
50.5131.8359.0335.9338.2225.07
Other Current Liabilities
42.2950.0154.67116.18115.44138.56
Total Current Liabilities
3,4793,2052,0643,0862,7052,266
Long-Term Debt
17.9724.14824.16512.37997.36480.75
Long-Term Leases
57.9359.3510.2813.2315.94-
Long-Term Unearned Revenue
101.42104.8884.6376.5784.9965.51
Long-Term Deferred Tax Liabilities
4349.8638.2837.3339.991.42
Other Long-Term Liabilities
6.17-----
Total Liabilities
3,7053,4433,0223,7263,8432,814
Common Stock
1,6161,6161,6161,6171,6171,244
Additional Paid-In Capital
587.65587.3587.29601.02603.59987.96
Retained Earnings
4,7134,6244,2043,5403,9153,123
Treasury Stock
-15.01-15.01--27.75-32.82-47.3
Comprehensive Income & Other
90.390.8584.6272.567.970.45
Total Common Equity
6,9926,9036,4925,8026,1715,378
Minority Interest
-3.54-3.54-3.51-3.47-3.4724.84
Shareholders' Equity
6,9886,8996,4885,7986,1675,403
Total Liabilities & Equity
10,69310,3439,5109,52410,0108,217
Total Debt
2,6722,3532,0792,5982,9712,051
Net Cash (Debt)
715.16358.171.13-706.06-1,581-1,133
Net Cash Growth
-31507.10%----
Net Cash Per Share
0.440.220.00-0.45-0.97-0.72
Filing Date Shares Outstanding
1,4841,6901,6161,4731,6531,543
Total Common Shares Outstanding
1,4841,6901,6161,4731,6531,543
Working Capital
4,4174,3154,9814,1755,5894,663
Book Value Per Share
4.714.094.023.943.733.49
Tangible Book Value
6,4686,3666,0255,5005,9265,139
Tangible Book Value Per Share
4.363.773.733.733.583.33
Buildings
--472.9481.48448.47268.49
Machinery
--1,3231,279981.72751.74
Construction In Progress
--137.4479.74250.62215.26
Source: S&P Global Market Intelligence. Standard template. Financial Sources.